GLYC 0.32 (-82.51%)
US38000Q1022BiotechnologyBiotechnology

GlycoMimetics (GLYC) Stock Highlights

0.32 | -82.51%
2024-05-07 03:31:14
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

Statistics

Range Today
0.31 0.42
Volume Today 40.75M
Range 1 Year
1.11 3.53
Volume 1 Year 72.05M
Range 3 Year
0.51 4.16
Volume 3 Year 331.47M
Range 10 Year
0.51 26.05
Volume 10 Year 1.02B

Highlights

Market Capitalization 117.94M (small)
Floating Shares 40.31M
Current Price 0.32
Price To Earnings -2.88
Price To Revenue 7.7K
Price To Book 3.07
Earnings Per Share -0.58
Payout Ratio 0%

Performance

Latest -82.51%
1 Month -88.61%
3 Months -89.71%
6 Months -76.12%
1 Year -79.08%
3 Years -86.5%
5 Years -97.37%
10 Years -97.28%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.